HKSE - Delayed Quote HKD
Lepu Biopharma Co., Ltd. (2157.HK)
4.490
-0.160
(-3.44%)
At close: May 9 at 4:08:05 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-196,394
-196,394
-250,836
-480,928
-621,736
Investing Cash Flow
-61,748
-61,748
83,937
-74,663
-3,892
Financing Cash Flow
232,084
232,084
-76,695
1,031,965
380,310
End Cash Position
401,286
401,286
426,015
669,397
155,168
Capital Expenditure
-61,748
-61,748
-41,199
-115,451
-219,501
Issuance of Capital Stock
213,379
213,379
0
739,227
0
Issuance of Debt
584,405
584,405
403,552
437,460
146,112
Repayment of Debt
-484,389
-484,389
-359,305
-80,976
-500
Free Cash Flow
-258,142
-258,142
-292,035
-596,379
-841,237
12/31/2021 - 2/23/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1541.HK IMMUNEONCO-B
6.440
+0.78%
688302.SS Hinova Pharmaceuticals Inc.
48.00
+7.02%
688315.SS Novogene Co., Ltd.
13.89
-3.07%
2257.HK Sirnaomics Ltd.
3.050
-0.33%
6660.HK AIM Vaccine Co., Ltd.
3.500
-3.31%
6826.HK Shanghai Haohai Biological Technology Co., Ltd.
23.300
-1.69%
1877.HK JUNSHI BIO
14.800
+0.14%
2197.HK Clover Biopharmaceuticals, Ltd.
0.199
-1.97%
9995.HK RemeGen Co., Ltd.
37.450
-3.48%
9688.HK Zai Lab Limited
23.600
+5.59%